CAF-Driven EMT and ECM Remodeling Programs Promote Mesothelioma Progression

Cancers · Published 2026-07-28 · DOI 10.3390/cancers18152424

Free full text

Authors (5)

Licun Wu, Hana Yun, Hamed Yasavoli Sharahi, Fatemeh Zaeimi, Marc de Perrot

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wu, L., Yun, H., Sharahi, H., et al. (2026). CAF-Driven EMT and ECM Remodeling Programs Promote Mesothelioma Progression. Cancers. https://doi.org/10.3390/cancers18152424

Related articles

• Pleural mesothelioma · Nature Reviews Disease Primers · 2025 · Cites or is cited by this article
• Trans-Presentation of IL-15 by IL15Rα Attenuates Tumor Immune Surveillance and Is Dispensable for IL-15-Dependent Tumor Growth Control · Cancers · 2026 · Same journal
• Survivorship Challenges in Metastatic Prostate Cancer in the Era of Prolonged Survival: A Review · Cancers · 2026 · Same journal
• Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study · Cancers · 2026 · Same journal
• Mapping Misconceptions in Neuroendocrine Tumor Nomenclature: A Scoping Review of National Database Studies and Clinical Implications · Cancers · 2026 · Same journal
• Interpreting Circulating Bile Acid Profiles in Pancreatic Cancer: The Role of Cholestasis and Its Management · Cancers · 2026 · Same journal
• Ex Vivo Line-Field Confocal Optical Coherence Tomography and Ex Vivo Fusion Confocal Microscopy for Lateral-Margin Assessment of Basal Cell Carcinoma in Correlation with Histopathology: A Prospective Pilot Diagnostic-Accuracy Study · Cancers · 2026 · Same journal
• Burden, Trends, and Future Projections of Multiple Myeloma in China from 1990 to 2023 · Cancers · 2026 · Same journal
• PTEN Protein Loss in Diagnostic Prostate Biopsies Is Associated with Gleason Score Upgrading in Radical Prostatectomy · Cancers · 2026 · Same journal
• Predictive Biomarkers of Systemic Therapy Response in Cutaneous Melanoma · Cancers · 2026 · Same journal